Forecast

Buy	0
Hold	1
Sell	0

News Go to news feed

Extendicare reports strong Q2 growth as acquisitions drive revenue and EBITDA

Extendicare posted Q2 revenue up 59.4% to C$611 million and adjusted EBITDA up 71% to C$68.3 million, driven by full-quarter contributions from CBI Home Health, acquired Revera homes and Closing the Gap. CBI added C$145.7 million of revenue and C$18.5 million of adjusted EBITDA; management expects a methodical 18–24 month integration delivering C$7.4 million of annual cost synergies. The company refinanced debt, lowering its weighted-average interest rate to 4.4% and reducing pro forma leverage to about 2.5x, while advancing six long-term-care redevelopment projects and planning to add 832 beds across four openings in 2027. Home health volumes rose sharply but margins were modestly pressured by investment in technology and support functions; management expects longer-term volume growth of about 6–8% annually. » More on finance.yahoo.com
Extendicare beats revenue forecasts, misses earnings and stock falls

Extendicare reported second-quarter 2026 revenue of 611 million CAD (+59.4%), well above expectations, while earnings of $0.319 per share missed the analyst estimate of $0.34. Adjusted EBITDA rose to 68.3 million CAD and adjusted results improved, but transaction, integration and refinancing costs weighed on net income. Management says the CBI integration is still in its early stages and expects 18–24 months for full integration, along with further investments in long-term care and home health. The stock fell about 8.7% in after-hours trading to $31.22 as investors put more weight on the earnings miss and near-term margin risks than on revenue growth. » More on de.investing.com
Extendicare beats Q1 2026 earnings expectations by a wide margin and stock rises

Extendicare reported Q1 2026 EPS of 0.422 CAD, surpassing the analyst estimate of 0.2033 CAD by 107.6%. Revenue was 465.2 million CAD (+24.2% y/y), slightly below expectations, while adjusted EBITDA and AFFO rose markedly. Strong volume growth in the home-healthcare segment (32.7%) was driven by acquisitions and organic growth; the acquisition of CBI Home Health was completed. The stock climbed 10.84% after hours to 33.44 CAD; management continues to reaffirm ambitious profit and revenue guidance for 2026/2027. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, EXTENDICARE INC. has already paid €0.22 in dividends. The last payout was in August.

Financials

In the last quarter, EXTENDICARE INC. had revenue of €376.83M and net profit of €19.03M

(EUR)	Jun 2026	YoY
Revenue	376.83M	57.61%
Gross profit	376.83M	57.61%
Net profit	19.03M	4.43%
EBITDA	38.66M	14.23%

Fundamentals

Metric	Value
Market capitalization	€1.86B
Number of shares	94.83M
52-week high/low	€24.29 - €7.84
Dividend yield	1.65%
Dividends TTM	€0.32
Next dividend	€0.0274
Beta	1.16
P/E ratio	23.90
PEG ratio	1.08
P/B ratio	7.44
P/S ratio	1.51

Company profile

Extendicare Inc. bietet über seine Tochtergesellschaften Pflege und Dienstleistungen für Senioren in Kanada an. Das Unternehmen bietet Langzeitpflegedienstleistungen, Seniorenwohnungen und häusliche Pflegedienstleistungen wie Krankenpflege, Ergo-, Physio- und Sprachtherapie und Unterstützung bei täglichen Aktivitäten sowie Vertrags- und Beratungsdienstleistungen für Dritte an. Das Unternehmen betreibt ein Netzwerk von 119 LTC-Heimen und Seniorenwohngemeinschaften sowie häusliche Pflegedienste unter den Marken Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist und SGP Purchasing Partner Network. Extendicare Inc. wurde 1968 gegründet und hat seinen Sitz in Markham, Kanada.